Atopic Dermatitis: Systemic Immunosuppressive Therapy

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Atopic dermatitis (AD) is a pruritic, relapsing skin disorder that negatively impacts the quality of life of those affected and that of their families. Treatment options for AD encompass a variety of emollients, topical corticosteroids, topical immunomodulators, phototherapy, and systemic agents. Such agents as systemic corticosteroids, cyclosporine, azathioprine, interferon-γ, methotrexate, and mycophenolate mofetil have been shown to be efficacious in the treatment of moderate-to-severe AD but are not officially approved for this purpose. In this article, we review some of the data supporting efficacy of these medications and discuss some of the adverse events associated with their use.

Original languageEnglish
Pages (from-to)151-155
Number of pages5
JournalSeminars in Cutaneous Medicine and Surgery
Issue number2
StatePublished - Jun 2008


Dive into the research topics of 'Atopic Dermatitis: Systemic Immunosuppressive Therapy'. Together they form a unique fingerprint.

Cite this